Minority participation in clinical trials continues to be a concern for industry professionals.  As stated in a blog posted on diversity in clinical trials, Dr. Kwame Osei says “minority participation in clinical trials remains lower than in the general population, with minorities making up only 10% of participants in multicenter clinical trials.”  Not only are minority participants lacking, but minority researchers are lacking as well.  The resulting danger of this reality lies in the tremendous amount of data that remains unknown, yet could have a substantial impact on clinical research.